R&D
A global pioneer in the development of new drugs
SK Biopharmaceuticals welcomes communication with prospective partners (industry-academia collaboration companies, research centers of academic institutions and other research centers at home and abroad). We look forward to hearing from partners interested in our pipelines and are always Open to diverse formats of business cooperation.
Areas of interest in research and development
CNS
- Neurology
- - Epilepsy
- - Neuropathic pain
- - Alzheimer’s disease
- - Parkinson's disease
- Psychiatry
- - Schizophrenia
- - Depression
- - Sleep disorders
- Rare diseases
Oncology (Anti-cancer treatments)
- Epigenetic modulation
- Ubiquitin-proteasome system
- Tumor microenvironment
- ECM remodeling
- Platform technologies
Possible formats of partnership
- In-licensing
- Out Licensing
- Co-development
- Co-marketing/co-promotion
- Joint venture
- Novel target proposal: Collaboration on new projects utilizing SK's drug library
- Value-up: Collaboration on hit/lead compound value-up using SK's vitro/vivo platform